Greg Simon, MD, MPH, is a psychiatrist and senior investigator well-known for his extensive research on practical approaches to improving mental health care. He seeks to develop and evaluate effective real-world strategies that support better mental health and wellness. Current areas of emphasis include identifying and assessing suicide risk, improving care for treatment-resistant depression, and early intervention for mental health conditions in children and youth.
Dr. Simon leads the Mental Health Research Network (MHRN), a consortium of research centers affiliated with 13 large health systems across the United States, including Kaiser Permanente Washington. This network, funded through a cooperative agreement with the National Institute of Mental Health, aims to improve the efficiency, relevance, and impact of mental health clinical and health services research. Now in its second five-year funding cycle, the MHRN is exploring a broad range of issues—including suicide prevention, improving heart health in people with serious mental illness, using electronic medical records to improve follow-up care for depression, and understanding the causes of racial and ethnic disparities in mental health care.
Dr. Simon and his MHRN colleagues are conducting several large studies across MHRN health systems, including:
Dr. Simon is an editor for the Cochrane Collaboration’s depression and anxiety review group, sits on the editorial board for General Hospital Psychiatry, and serves on the advisory board for the National Institutes of Health’s All of Us Program (formerly Precision Medicine Initiative). Earlier, he served on the editorial boards of Psychiatric Services and Psychological Medicine and chaired the scientific advisory board for the Depression and Bipolar Support Alliance. Dr. Simon has practiced adult psychiatry in Kaiser Permanente Washington's Mental Health and Wellness Service since 1990 and is a research professor in psychiatry and behavioral sciences at the University of Washington.
Depression; bipolar disorder; suicide prevention; self-management; treatment adherence
Comorbidity of mental health conditions with obesity, diabetes, heart disease, and substance use disorders.
Ludman EJ, Simon GE. Coordinated multi-component treatment in primary care improves anxiety in adults with multiple anxiety disorders compared with usual care. Evid Based Ment Health. 2010;13(4):121. PubMed
Simon GE, Rohde P, Ludman EJ, Jeffery RW, Linde JA, Operskalski BH, Arterburn D. Association between change in depression and change in weight among women enrolled in weight loss treatment. Gen Hosp Psychiatry. 2010;32(6):583-9. Epub 2010 Oct 27. PubMed
Simon GE, Rohde P, Ludman EJ, Jeffery RW, Linde JA, Operskalski BH, Arterburn D, Finch EA. Is success in weight loss treatment contagious (do attendance and outcomes cluster within treatment groups)? Obes Res Clin Pract. 2010;4(4):283-291. PubMed
Linde JA, Simon GE, Ludman EJ, Ichikawa LE, Operskalski BH, Arterburn D, Rohde P, Finch EA, Jeffery RW. A randomized controlled trial of behavioral weight loss treatment versus combined weight loss/depression treatment among women with comorbid obesity and depression. Ann Behav Med. 2011 Feb;41(1):119-30. Epub 2010 Sep 28. PubMed
Simon GE, Perlis RH. Personalized medicine for depression: can we match patients with treatments? Am J Psychiatry. 2010 Dec;167(12):1445-55. Epub 2010 Sep 15. Review. PubMed
Simon GE, Ludman EJ. Predictors of early dropout from psychotherapy for depression in community practice. Psychiatr Serv. 2010;61(7):684-9. PubMed
Tutty S, Spangler DL, Poppleton LE, Ludman EJ, Simon GE. Evaluating the effectiveness of cognitive-behavioral teletherapy in depressed adults. Behav Ther. 2010;41(2):229-36. Epub 2010 Jan 6. PubMed
Ludman EJ, Ichikawa LE, Simon GE, Rohde P, Arterburn D, Operskalski BH, Linde JA, Jeffery RW. Breast and cervical cancer screening specific effects of depression and obesity. Am J Prev Med. 2010;38(3):303-10. PubMed
Ludman E, Simon GE, Ichikawa LE, Operskalski BH, Arterburn D, Linde JA, Jeffery RW, Rohde P, Finch EA. Does depression reduce the effectiveness of behavioral weight loss treatment? Behav Med. 2010;35(4):126-34. PubMed
Ludman EJ, Russo JE, Katon WJ, Simon GE, Williams LH, Lin EH, Heckbert SR, Ciechanowski P, Young BA. How does change in depressive symptomatology influence weight change in patients with diabetes? Observational results from the Pathways longitudinal cohort. J Gerontol A Biol Sci Med Sci. 2010 Jan;65(1):93-8. Epub 2009 Oct 12. PubMed
Safety planning and risk screening improved outcomes for adult patients.
A new grant funds modeling work to make personalized treatment possible.
KPWHRI research finds ways to increase use of a firearm safety tool.
Study finds that many patients who might benefit from clozapine don’t receive it.
KPWHRI researchers are contributing to better mental health care for people nationwide.